RxDoctor Payments Data

Amber Cano

Family · Avondale, AZNPI 1518618057

Payments from drug & device makers

$9,372in general payments, 2019–2025

Across 357 payments — averaging $26.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$790
  • Ipsen Biopharmaceuticals, Inc$624
  • Johnson & Johnson$533
  • Daiichi Sankyo Inc.$473
  • Novartis$442
  • Merck$425
  • plus $6K from 54 others

What the payments were for

  • Speaking & faculty fees$4004%
  • Food & beverage$8,35889%
  • Education$6147%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)28$790
Ipsen Biopharmaceuticals, Inc5$624
Johnson & Johnson24$533
Daiichi Sankyo Inc.18$473
Novartis23$442
Merck20$425
Pfizer17$400
Jazz Pharmaceuticals Inc.9$372
AbbVie17$312
Lilly USA, LLC12$307
Incyte Corporation12$305
AVEO Pharmaceuticals, Inc.7$288
Sanofi11$261
Genentech USA, Inc.10$253
Inari Medical, Inc.1$199
Bristol Myers Squibb10$197
Eisai Inc.8$179
Bayer8$162
Genmab U.S., Inc.6$158
EMD Serono, Inc.7$148
Stemline Therapeutics Inc.6$145
Array Biopharma Inc8$141
Exelixis Inc.6$136
Astellas Pharma US Inc6$134
Takeda Pharmaceuticals U.S.A., Inc.6$128
Epizyme, Inc.1$124
Tempus AI, Inc1$121
Geron Corporation4$111
E.r. Squibb & Sons, L.L.C.5$110
Rigel Pharmaceuticals, Inc.4$97
ADC Therapeutics America, Inc.4$96
Regeneron Healthcare Solutions, Inc.3$94
Sobi, Inc5$78
Tersera Therapeutics LLC2$73
Pharmaessentia USA Corporation3$72
Seagen Inc.2$66
Taiho Oncology, Inc.2$66
Boehringer Ingelheim2$54
Pharmacyclics LLC, An Abbvie Company3$52
Blueprint Medicines Corporation2$52
Deciphera Pharmaceuticals Inc.2$49
Puma Biotechnology, Inc.2$44
Beone Medicines USA, Inc.2$42
Sun Pharmaceutical Industries Inc.1$39
Agios Pharmaceuticals, Inc.2$36
Karyopharm Therapeutics Inc.2$33
Adaptive Biotechnologies Corporation2$31
Gilead1$26
Progenics Pharmaceuticals, Inc.1$25
Springworks Therapeutics, Inc.1$24
Kyowa Kirin, Inc.1$23
Nuvation Bio Inc.1$22
Coherus Oncology, Inc.1$22
Beigene USA, Inc.1$21
Clovis Oncology, Inc.1$21
G1 Therapeutics, Inc.1$20
Tolmar Pharmaceuticals, Inc.1$19
Hologic Sales And Service, LLC1$19
Novocure Inc.1$17
Legend Biotech USA Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,372 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$1,041
Medicare patients
12
Services billed
12

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Avondale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →